Paul Shelton is currently the US Director of Clinical Development at P+F Products + Features GmbH. Previously, Paul held roles such as Senior Principal Market Development Manager at Keystone Heart and Minimally Invasive Manager, EP at AtriCure, Inc./SentreHEART. With extensive experience in the medical sales industry, Paul has consistently achieved sales goals and developed successful market strategies. Their background includes positions at companies such as SentreHEART, ev3, Cordis, Boston Scientific, and Astra Zeneca. Paul's education includes a BBA in Marketing/Psychology from Francis Marion University and a preceptorship in Cardiology/Immunology from Tufts University School of Medicine.
Current role
Director Clinical Development at Alpha Tau Medical
Director Clinical Development at Xintela AB (publ)
Director Clinical Development at Neurolief
Director Clinical Development at Intercept Pharmaceuticals
Director Clinical Development at Alector